Pervasive Neurotechnology: The Digital Revolution Meets the Human Brain

The Digital

Revolution Meets

The Human Brain

= Pervasive

Neurotech

June 30th, 2015

Alvaro Fernandez & Nikhil

Sriraman

The team behind the new Pervasive

Neurotechnology report

Alvaro Fernandez

Editor-In-Chief

Nikhil Sriraman

IP Analyst

Brian Gurewitz

Technology Analyst

Olivier Oullier

Science Advisor

Today’s Agenda

1-1.20pm ET: Five Key Trends Driving

Neurotechnology to Become Pervasive

1.20-1.40pm ET: How Nielsen, Advanced

Neuromodulation Systems, Medtronic,

Microsoft and Brainlab emerged as

leading IP Holders

1.40-2pm ET: Q&A

Five key trends and insights

1. Exponential growth since 2010, close to/ supporting

commercialization

2. Large companies developing significant portfolios,

often under the radar

3. Evolution from invasive to pervasive impact on

medicine, health, entertainment and business

4. Multi-sensor, multi-variable analysis and use of data

(EEG, eye-tracking, heart rate, computer use,

patient…)

5. Aggressive “build” AND strategic/ tactical “buy”

Today’s Agenda

1-1.20pm ET: Five Key Trends Driving

Neurotechnology to Become Pervasive

1.20-1.40pm ET: How Nielsen, Advanced

Neuromodulation Systems, Medtronic,

Microsoft and Brainlab emerged as

leading IP Holders

1.40-2pm ET: Q&A

How we identified the population of

non-invasive neurotech patent filings

4K+ US non-invasive

neurotech patents

10K+ GLOBAL pubs

yielded w/ similar

process

How we assessed patent portfolios

The SharpBrains’ IP Strength Index:

Quantity + Quality

Volume + Relevance Fwd Cites + Scope + Key Patents

IP portfolio strength of 800+ organizations assessed

via SharpBrains Index (Report includes detailed

profiles of top 30, and ranks top 100)

How the Leading IP Holders emerged

#1: Nielsen

(NYSE:NLSN)

#1: Nielsen

(NYSE:NLSN)

#2: Advanced Neuromodulation Systems

(St Jude Medical -- NYSE: STJ)

#3: Medtronic

(NYSE:MDT)

#4: Microsoft

(NASDAQ:MSFT)

#4: Microsoft

(NASDAQ:MSFT)

#5: Brainlab

206-page report includes

Chapter I. Scoping the

Opportunity

Chapter II. The State of

Pervasive Neurotechnology

Patents

Chapter III. The Patent

Holders: Ranking of Top 100

Assignees, and Detailed

Profiles of 30 Leaders

Chapter IV. Analysis of 50

key Active Patents

Check out the full

Table of Contents &

Figures

Individual License………..….$395

Enterprise License…………$3,995

Up to 10 users

Tailored report of patent

landscape

Competitive analysis

1-hour conference call/

webinar